New Zealand markets closed

Boston Scientific Corporation (BSX)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
47.66-0.84 (-1.73%)
At close: 04:00PM EST
47.50 -0.16 (-0.34%)
After hours: 05:45PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 68.85B
Enterprise value 77.45B
Trailing P/E 106.82
Forward P/E 24.69
PEG ratio (5-yr expected) 2.20
Price/sales (ttm)5.46
Price/book (mrq)3.90
Enterprise value/revenue 6.11
Enterprise value/EBITDA 32.08

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 37.93%
S&P500 52-week change 3-9.08%
52-week high 348.87
52-week low 334.98
50-day moving average 346.05
200-day moving average 341.75

Share statistics

Avg vol (3-month) 36.57M
Avg vol (10-day) 38.85M
Shares outstanding 51.43B
Implied shares outstanding 6N/A
Float 8N/A
% held by insiders 10.22%
% held by institutions 194.57%
Shares short (12 Jan 2023) 415.61M
Short ratio (12 Jan 2023) 42.39
Short % of float (12 Jan 2023) 41.09%
Short % of shares outstanding (12 Jan 2023) 41.09%
Shares short (prior month 14 Dec 2022) 414.35M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 305 Nov 2003

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Dec 2022

Profitability

Profit margin 5.50%
Operating margin (ttm)16.03%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)4.07%

Income statement

Revenue (ttm)12.68B
Revenue per share (ttm)8.86
Quarterly revenue growth (yoy)3.70%
Gross profit (ttm)8.68B
EBITDA 3.16B
Net income avi to common (ttm)643M
Diluted EPS (ttm)0.42
Quarterly earnings growth (yoy)47.40%

Balance sheet

Total cash (mrq)N/A
Total cash per share (mrq)N/A
Total debt (mrq)N/A
Total debt/equity (mrq)50.65
Current ratio (mrq)N/A
Book value per share (mrq)12.32

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A